WILMINGTON, Del.--(BUSINESS WIRE)--
Incyte Corporation (INCY) announced today that it has scheduled its first quarter conference call for 8:30 a.m. ET on Thursday, May 2, 2013. The schedules for the press release and conference call are as follows:
|-- Q1 2013 Press Release:||May 2, 2013 at 7:00 a.m. ET|
|-- Q1 2013 Conference Call:||May 2, 2013 at 8:30 a.m. ET|
|-- Domestic Dial In Number:||877-407-8037|
|-- International Dial In Number:||201-689-8037|
|-- Conference ID #||412369|
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 412369.
The conference call will also be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts.
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, please visit the Company's web site at www.incyte.com.
- Investment & Company Information
Pamela M. Murphy
Vice President, Investor Relations & Corporate Communications